Related Experiment Video
Updated: Jun 4, 2025
05:46
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
1.6K
Metastatic conjunctival melanoma: a multicentre international study.
Puneet Jain1, Paul T Finger2, Maria Filì3
1Eye Cancer Center, New York, New York, USA.
The British Journal of Ophthalmology
|December 18, 2024
Summary
Metastatic conjunctival melanoma affects 10% of patients, with higher risks linked to AJCC cT3-category, ulceration, and location. Early metastasis at presentation indicates a poorer prognosis and shorter survival.
Area of Science:
- Ophthalmology
- Oncology
- Cancer Research
Background:
- Conjunctival melanoma is a rare ocular malignancy.
- Understanding its metastatic potential is crucial for patient outcomes.
Purpose of the Study:
- To identify clinical findings and risk factors associated with metastatic conjunctival melanoma.
- To determine the incidence, cumulative risk, and mortality rates of systemic metastasis.
Main Methods:
- A large clinical case series was compiled from 10 ophthalmic oncology centers across 9 countries.
- Data included patient demographics, primary tumor characteristics, and metastasis development.
- Main outcomes measured were incidence, cumulative risk of metastasis, and patient mortality.
Main Results:
- Of 288 patients, 29 (10%) developed metastasis.
- AJCC cT3-category, tumor ulceration, and conjunctival location were associated with increased metastatic risk.
- The 10-year cumulative risk of metastasis was 22.3%; each AJCC cT category increase raised metastasis risk by 89%.
Conclusions:
- Metastatic conjunctival melanoma is associated with specific tumor characteristics.
- Patients presenting with metastasis, particularly AJCC cT3 disease, have a poorer prognosis.
- Early detection and risk stratification are vital for managing conjunctival melanoma.
